Benjamin Verret

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Quality of Life of Adolescents and Young Adults with Cancer at Gustave Roussy Institute: The Role of Management in Enhancing Care and Ensuring Performance.

Quality of Life of Adolescents and Young Adults with Cancer at Gustave Roussy Institute: The Role of Management in Enhancing Care and Ensuring Performance.

Journal: Journal of adolescent and young adult oncology

Published: September 02, 2026

Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives.

Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives.

Journal: Current treatment options in oncology

Published: June 05, 2026

HMGA2::NCOR2 fusion-driven giant cell tumors: Diagnosis and treatment.

HMGA2::NCOR2 fusion-driven giant cell tumors: Diagnosis and treatment.

Journal: Critical reviews in oncology/hematology

Published: February 13, 2026

Systemic treatment of bone sarcoma, soft tissue sarcoma, GIST

Systemic treatment of bone sarcoma, soft tissue sarcoma, GIST

Journal: La Revue du praticien

Published: January 23, 2026

Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarker.

Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarker.

Journal: Clinical and experimental medicine

Published: January 16, 2026

Transitioning to adult oncology for adolescents and young adults (AYAs): The experience of an AYA unit

Transitioning to adult oncology for adolescents and young adults (AYAs): The experience of an AYA unit

Journal: Medecine sciences : M/S

Published: September 08, 2025

Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

Journal: Cancer

Published: May 27, 2025

Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database.

Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2025

Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial.

Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 05, 2025

Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics.

Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics.

Journal: Cancer communications (London, England)

Published: April 05, 2025

Corrigendum to "HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome" [Eur J Cancer 211 (2024) 114307].

Corrigendum to "HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome" [Eur J Cancer 211 (2024) 114307].

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2025

Contraindication to surgery in primary retroperitoneal sarcoma: Retrospective series on 20years of practice in a high-volume sarcoma center.

Contraindication to surgery in primary retroperitoneal sarcoma: Retrospective series on 20years of practice in a high-volume sarcoma center.

Journal: Journal of visceral surgery

Published: February 25, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026